Navigating Drug Pricing Challenges

This chapter delves into the complexities of drug pricing in the U.S., highlighting the balance between fostering pharmaceutical innovation and implementing cost-reduction policies. It examines investor sentiment and market dynamics in response to regulatory changes, while also discussing the implications for biotech investments and potential mergers in the industry.